SEC Filings | EyePoint Pharmaceuticals

Form	Description	Filing date	View
6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Jul 02, 2007	View HTML 0001144204-07-034582.pdf 0001144204-07-034582.rtf 0001144204-07-034582.xls
6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Jul 02, 2007	View HTML 0001144204-07-034593.pdf 0001144204-07-034593.rtf 0001144204-07-034593.xls
6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Jun 28, 2007	View HTML 0001144204-07-033903.pdf 0001144204-07-033903.rtf 0001144204-07-033903.xls
6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	Jun 19, 2007	View HTML 0001144204-07-032505.pdf 0001144204-07-032505.rtf 0001144204-07-032505.xls
424B3	Form of prospectus reflecting facts events constituting substantive change from last form	Jun 11, 2007	View HTML 0001144204-07-031298.pdf 0001144204-07-031298.rtf 0001144204-07-031298.xls
EFFECT	EFFECT	Jun 11, 2007	View HTML 9999999995-07-002328.pdf 9999999995-07-002328.rtf
F-3	Registration statement for certain foreign private issuers offered for certain transactions	May 24, 2007	View HTML 0001144204-07-028476.pdf 0001144204-07-028476.rtf 0001144204-07-028476.xls
REGDEX	REGDEX	May 21, 2007	View HTML
6-K	Report of foreign issuer rules 13a-16 and 15d-16 of the Securities Exchange Act	May 18, 2007	View HTML 0001144204-07-027235.pdf 0001144204-07-027235.rtf 0001144204-07-027235.xls
REGDEX	REGDEX	May 18, 2007	View HTML

Data provided by Kaleidoscope.